Does RAMIPRIL Cause Lung opacity? 26 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Lung opacity have been filed in association with RAMIPRIL (Ramipril). This represents 0.1% of all adverse event reports for RAMIPRIL.
26
Reports of Lung opacity with RAMIPRIL
0.1%
of all RAMIPRIL reports
17
Deaths
25
Hospitalizations
How Dangerous Is Lung opacity From RAMIPRIL?
Of the 26 reports, 17 (65.4%) resulted in death, 25 (96.2%) required hospitalization, and 17 (65.4%) were considered life-threatening.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which RAMIPRIL Alternatives Have Lower Lung opacity Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE